AI assistant
GlaxoSmithKline PLC — Director's Dealing 2016
Jul 19, 2016
5262_dirs_2016-07-19_8342ddc5-c3ee-48cd-b903-8e29d044c115.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 6591E
GlaxoSmithKline PLC
19 July 2016
GlaxoSmithKline plc (the 'Company')
Transaction notification
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Mr N Hirons
b)
Position/status
SVP, Global Ethics & Compliance
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
American Depositary Shares ('ADSs')
ISIN: US37733W1053
b)
Nature of the transaction
Increase in notional interest in ADSs following the re-investment of dividends paid to shareholders on 14 July 2016 on ADSs held in the Company's 2009 Performance Share Plan.
c)
Price(s) and
volume(s)
| Price(s) | Volume(s) |
| $43.87 | 87.393 |
d)
Aggregated information
Aggregated volume Price
n/a (single transction)
e)
Date of the transaction
2016-07-14
f)
Place of the transaction
n/a
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHQKLFFQDFEBBQ
//<![CDATA[$.ajaxSetup({headers: {'__RequestVerificationToken':'YOv5noZhYkM2_cT0RD_DoJUhkJGaT5d2Rnvw7tB1AXh3rBKDtPyJz-TiBUbq80ED__0ULcJv2a6REIRNuKP4QxeB96PDSdCJ41fJGAooRW01:V0DC4h2X3Sf6YkaxY0QGNhp2dH4bZVd3SiJ1jDuJGLAJVmcF6arlxP_U_jcQr1idH3ByYLwhIx2NExPoVBbJ1XO43ndmu4eD6U75NCD-oWw1'}});//]]>